The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Gide Loyrette Nouel A.A.R.P.I.

22 COURS ALBERT IER, 75008 PARIS, FRANCE
Tel:
Work +33 1 40 75 60 00
Email:
Web:
https://www.gide.com

Emmanuel Larere

Tel:
Work +33 (0)1 40 75 61 70
Email:
Gide Loyrette Nouel A.A.R.P.I.

Work Department

Intellectual Property, Telecommunications, Media & Technology

Position

Emmanuel Larere focuses his practice on non-contentious and contentious patent and trademark matters. With over 20 years’ experience in these fields, he is a renowned specialist in trademark law, defending and advising some of the world's leading brands in the luxury goods, sports apparel, and jeanswear sectors. Emmanuel's patent litigation practice covers life science, including biotech, technologies and traditional industrial sectors. He is a member of several professional associations, including AIPPI (Association Internationale pour la Protection de la Propriété Intellectuelle, member of the Communication Committee, former Vice-President of the French group, current Chairman of the French Trademarks commission), AAPI (Association des Avocats de Propriété Intellectuelle, current General Secretary), INTA (International Trademark Association).

Languages

French, English.


France: Industry focus

Healthcare and life sciences

Within: Healthcare and life sciences

Gide Loyrette Nouel A.A.R.P.I.’s healthcare and life sciences group has strong intellectual property, corporate and competition law expertise and is led by Grégoire Triet, Anne Tolila and Dimitri Dimitrov, respectively. Jean-Hyacinthe de Mitry advised biopharmaceutical company Annapurna Therapeutics on its merger with Avalanche Biotechnologies, and Raphaëlle Dequiré-Portier teamed up with Emmanuel Larere to represent Ono and Bristol-Myers Squibb in a multijurisdictional patent litigation pertaining to an innovative cancer treatment. In other recent highlight work, Arnaud Michel represented Merck and five of its subsidiaries in trade mark infringement and unfair competition proceedings regarding the use of the name ‘Merck’ in France, and Dimitrov assisted a manufacturer of medical devices with the review of its contracts in light of French distribution law provisions. Other notable clients include Johnson & Johnson, Shionogi and Guerbet.

[back to top]

France: Intellectual property

Patents

Within: Leading individuals

Emmanuel Larere - Gide Loyrette Nouel A.A.R.P.I.

Within: Patents

Gide Loyrette Nouel A.A.R.P.I.’s ‘very strong and highly responsive’ intellectual property lawyers are particularly ‘well-known and connected’ in the medical devices and pharmaceutical sectors. Emmanuel Larere recently teamed up with Raphaëlle Dequiré-Portier to represent Ono and Bristol-Myers Squibb in a multijurisdictional patent dispute against Merck with regards to an innovative immunological treatment for cancer, while Grégoire Triet represented Shionogi in two infringement claims against Merck and its subsidiaries pertaining to a HIV drug. In the consumer products space, the team defended Delica and its distributor Mifroma against patent infringement claims brought by Nestlé concerning its marketing of coffee capsules compatible with the ‘Dolce Gusto’ machines. Newly promoted partner Jean-Hyacinthe de Mitry has experience in handling trade secret and ‘know-how’ protection matters; he is a notable contact alongside ‘driven, client-oriented and very strong professional’ and associate Emma Leguillon.

[back to top]

Trade marks, designs and copyright

Within: Leading individuals

Emmanuel Larere - Gide Loyrette Nouel A.A.R.P.I.

Within: Trade marks, designs and copyright

Gide Loyrette Nouel A.A.R.P.I. advises clients such as Dior, Tag Heuer and Johnson & Johnson on the full spread of contentious and non-contentious trade mark, design and copyright matters. Raphaëlle Dequiré-Portier recently represented Levi Strauss in a cross-border trade mark infringement claim against Dogg Label while Arnaud Michel acted for Merck and five of its French subsidiaries in a trade mark and name infringement action against MSD regarding the use of the ‘Merck’ sign in France. Emmanuel Larere defended Marks & Spencer in a major trade mark dispute brought by Auchan in connection with the client’s ‘simply M&S’ brand, and Grégoire Triet, who ‘takes a holistic view’ and provides ‘pragmatic advice’, is representing Fondazione Prada in copyright infringement proceedings brought by a former Naf Naf designer.

[back to top]


Back to index

Legal Developments in France

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • The new French regulation applying to national insurance contributions for managers and shareholders

    French insurance contributions on executive and shareholder remuneration (pay + dividends) have been substantially increased by the National Insurance Funding for 2013 Act, No. 2012-1404, of 17th December 2012. Until 31st December 2012, all dividends were subject to national insurance contributions on unearned income but henceforth, under Article L136-3 of the National Insurance Code, amended by Act No. 2012-1404, certain dividends   are considered as pay received by executives and shareholders and are therefore subject to the national insurance contributions on pay. The Act also abolished the ceiling on health insurance contributions payable by the self-employed and all this means that businesses must rethink the way that they have been structured until now.
  • CHINA - PERSONAL TAXATION AND SOCIAL SECURITY : CHINESE AND FOREIGN NATIONALS ON AN EQUAL FOOTING

    The People's Republic of China has initiated an overhaul of its social security system, reformed the personal taxation regime and has extended the scope of these laws to foreigners residing in China.
  • MOROCCO TO BECOME THE LEADING FINANCIAL PLACE IN AFRICA

    The Kingdom of Morocco is supporting the ambition of becoming the leading financial place for Africa. In this context, a wave of draft laws is to be passed and implemented within the following months, amongst which, the Law No. 53.08, setting up a new financial authority, and the Law No. 54.08, reforming public offering rules, are of paramount importance to Moroccan and foreign issuers, and financial institutions.
  • ACQUISITIONS IN CHINA : ASSET OR SHARE DEAL?

    The opportunities offered to foreign investors by the Chinese mergers and acquisitions market are increasing every year: in 2010, transactions involving foreign companies came to 60.1 billion euros, an increase of 21.2% compared with 2009. Seen from the West, where markets are declining, all sectors of the Chinese economy seem to be undergoing promising development and the statistics indicate that the Middle Empire will be a lasting springboard for growth.
  • Prime de Partage des Profits

    Le dispositif L’article 1er de la loi de financement rectificative de la Sécurité sociale pour 2011 oblige les sociétés commerciales de 50 salariés et plus, dont les dividendes par part sociale ou par action sont en augmentation par rapport à la moyenne des deux années précédentes, à verser une prime à l’ensemble de leurs salariés
  • BULGARIA MARKET OVERVIEW

    Types of investors The private equity (PE) funds that are active in Bulgaria are not raised or registered in the country. Some Bulgarian PE funds were raised recently, but there are no statistics as to the sources of their funding, their number, the funds that were accumulated, etc.
  • RECENT DEVELOPMENTS REGARDING COMMITMENTS

    THE PROCEDURE IS CLARIFIED, BUT MAY COMMITMENTS APPLY WITHOUT LIMIT?
  • Landmark decision by French Competition Authority in conditioned LPG case

    cartel case closed after discovery that leniency application was largely based on forgeries and rejection of collective dominant position objection.
  • 2012 supplementary budget

    The second supplementary budget published in the Official Gazette September 19, 2011 provides for two key measures that affect the deferral of tax losses and taxation of capital gains realized on the sale of equity securities .
  • Actualité législative fiscale

    Au delà des mesures applicables à l’ensemble des contribuables (telles que la limitation du report des déficits ou la réforme du mode de calcul des plus values sur cessions de participations),le plan de réduction des déficits annoncé le 24 août dernier par le gouvernement comprend des mesures qui intéressent spécifiquement les acteurs du secteur financier.